Delivery Order SPE2DB22D2005-SPE2DB25FJTC6
Award Date 9/17/25
Potential Completion Date 9/18/25
Potential Value $99K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,996.67 for Zepbound (tirzepatide) 5 mg/0.5 mL pen injections on August 26, 2025, with an ultimate completion date of August 27, 2025. This is a firm fixed-price, non-set-aside contract to be performed at the company's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal pharmaceutical supply relationship,...
- The Defense Logistics Agency awarded a $16,652.51 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Zepbound (tirzepatide) 5 mg/0.5 mL pen injectors. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by July 31, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase requisition under...
- The Defense Logistics Agency awarded a $19,064.54 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (tirzepatide) 10 mg/0.5 mL pen injections on July 25, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 28, 2025, was competitively awarded with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (tirzepatide) 5 mg/0.5 mL pen injections valued at $11,887.80. This is a firm fixed price delivery order with an ultimate completion date of May 28, 2025, and was competitively awarded without set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a pharmaceutical distributor and critical federal...
- The Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order for $12,138.60 on September 2, 2025, for the supply of Zepbound (tirzepatide) 15 mg/0.5 mL pen injections. This competitive award, issued without set-aside designation, will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of September 3, 2025. The contract utilizes firm fixed pricing under a delivery order structure,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,481.93 by the Defense Logistics Agency on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, firm fixed-price contract is for the supply of Zepbound (tirzepatide) 12.5 mg/0.5 mL pen auto-injectors in 0.5 mL dosages. The award carries no set-aside designation and represents a child order under a larger contract vehicle supporting federal...
- The Defense Logistics Agency awarded a delivery order valued at $29,274.42 to AmerisourceBergen Drug Corp for the supply of Zepbound (tirzepatide) 10 mg/0.5 mL pens on August 6, 2025, with completion targeted for August 7, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contractual relationship with DLA for...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a firm fixed-price delivery order from the Defense Logistics Agency (DLA) valued at $8,653.84 for Zepbound (tirzepatide) 15 mg/0.5 mL pens. The award, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a non-set-aside, competitively awarded contract for pharmaceutical supply to support federal medical procurement needs. The delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on March 17, 2025, with an ultimate completion date of March 18, 2025. This non-set-aside contract, valued at $7,589.24, covers the supply of Zepbound (tirzepatide) 5 mg/0.5 mL pens in 0.5 mL units to support federal medical procurement needs. The delivery order was issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,465.19 to AmerisourceBergen Drug Corp for the supply of Zepbound (tirzepatide) 10 mg/0.5 mL pen injectors on April 24, 2025, with completion scheduled for April 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction...